Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice

Neuroscience Letters

Volumn 232, Issue 3, 1997, Pages 167-170

  Kakinuma, Yoshihiko ^a   Hama, Hiroshi ^a   Sugiyama, Fumihiro ^a   Goto, Katsutoshi ^a   Murakami, Kazuo ^a   Fukamizu, Akiyoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Angiotensin II; Angiotensin IV; Angiotensinogen; Apoptosis; Cerebellum; Hippocampus

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN II [3-8]; ANGIOTENSINOGEN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; CELL PROTECTION; CEREBELLUM; CONTROLLED STUDY; ETIOLOGY; FETUS; HIPPOCAMPUS; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; APOPTOSIS; CELL COUNT; HIPPOCAMPUS; MICE; MICE, KNOCKOUT; NEUROTRANSMITTER AGENTS;

EID: 0030845329     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00605-8     Document Type: Article

References (24)

1. Bottenstein, J. and Sato, G., Growth of a rat neuroblastoma cell line in serum-free supplemented medium, Proc. Natl. Acad. Sci. USA, 76 (1979) 514-517.
2. De Oliveira, A.M., Viswanathan, M., Heemskerk, F.M.J. and Saavedra, J.M., Expression of a novel angiotensin II receptor subtype in gerbil brain, Brain Res., 705 (1995) 177-187.
3. Dudley, D.T., Panek, R.L., Major, T.C., Lu, G.H., Bruns, R.F., Klinkefus, B.A., Hodges, J.C. and Weishaar, R., Subclasses of angiotensin II binding sites and their functional significance, Mol. Pharmacol., 38 (1990) 370-377.
4. Esther, C.R. Jr., Howard, T.E., Marino, E.M., Goddard, J.M., Capecchi, M.R. and Bernstein, K.E., Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology and reduced male fertility, Lab. Invest., 74 (1996) 953-965.
5. Harding, J.W., Cook, V.I., Miller-Wing, A.V., Hanesworth, J.M., Sardinia, M.F., Hall, K.L., Stobb, J.W., Swanson, G.N., Coleman, J.K.M., Wright, J.W. and Harding, E.C., Identification of an AngII(3-8) [Ang IV] binding site in guinea pig hippocampus, Brain Res., 583 (1992) 340-343.
6. 125I]angiotensins in rat, J. Neurochem., 46 (1986) 1292-1297.
7. Ichiki, T., Labosky, P.A., Shiota, C., Okuyama, S., Imagawa, Y., Fogo, A., Niimura, F., Ichikawa, I., Hogan, B.L. and Inagami, T., Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor, Nature, 377 (1995) 748-750.
8. Ito, M., Oliverio, M.I., Mannon, P.J., Best, C.F., Maeda, N., Smithies, O. and Coffman, T.M., Regulation of blood pressure by the type 1A angiotensin II receptor gene, Proc. Natl. Acad. Sci. USA, 92 (1995) 3521-3525.
9. Kambayashi, Y., Bradhan, S., Takahashi, K., Tsuzuki, S., Hamakubo, T., and Inagami, T., Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition, J. Biol. Chem., 268 (1993) 24543-24546.
10. Mashima, T., Naito, M., Kataoka, S., Kawai, H. and Tsuruo, T., Aspartate-based inhibitor of interleukin-1β-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells, Biochem. Biophys. Res. Commun., 209 (1995) 907-915.
11. Miller-Wing, A.V., Hanesworth, J.M., Sardinia, M.F., Hall, K.L., Wright, J.W., Speth, R.C., Grove, K.L. and Harding, J.W., Central angiotensin IV binding sites: distribution and specificity in guinea pig brain, J. Pharmacol. Exp. Ther., 266 (1993) 1718-1726.
12. Milsted, A., Barna, B.P., Ransohoff, R.M., Brosnihan, K.B. and Ferrario, C.M., Astrocyte cultures derived from human brain tissue express angiotensinogen mRNA, Proc. Natl. Acad. Sci. USA, 87 (1990) 5720-5723.
13. Mukoyama, M., Nakajima, M., Horiuchi, M., Sasamura, H., Pratt, R.E. and Dzau, V.J., Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors, J. Biol. Chem., 268 (1993) 24539-24542.
14. Murphy, T.J., Alexander, Rw., Griendling, K.K., Runge, M.S. and Bernstein, K.E., Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor, Nature, 351 (1991) 233-236.
15. Niimura, F., Labosky, P.A., Kakuchi, J., Okubo, S., Yoshida, H., Oikawa, T., Ichiki, T., Naftilan, A.J., Fogo, A., Inagami, T. and Ichikawa, I., Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation, J. Clin. Invest., 96 (1995) 2947-2954.
16. Roberts, K.A., Krebs, L.T., Kramar, E.A., Shaffer, M.J., Harding, J.W. and Wright, J.W., Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin AII and IV in rats, Brain Res., 682 (1995) 13-21.
17. Sasaki, K., Yamano, Y., Bardhan, S., Iwai, N., Murray, J.J., Hasegawa, M., Matsuda, Y. and Inagami, T., Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor, Nature, 351 (1991) 230-233.
18. Shibouta, Y., Inada, Y., Ojima, M., Wada, T., Noda, M., Sanada, T., Kubo, K., Kohara, Y., Naka, T. and Nishikawa, K., Pharmacological profile of a highly potent and long acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylic acid (CV-11974), and its prodrug, (±)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylate (TCV-116), J. Pharmacol. Exp. Ther., 266 (1993) 114-120.
19. Sugaya, T., Nishimatsu, S., Tanimoto, K., Takimoto, E., Yamagishi, T., Imamura, K., Goto, S., Imaizumi, K., Hisada, Y., Otsuka, A., Uchida, H., Sugiura, M., Fukuta, K., Fukamizu, A. and Murakami, K., Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia, J. Biol. Chem., 270 (1995) 18719-18722.
20. Sugiyama, F., Tanimoto, Y., Kato, H., Nomura, T., Taniguchi, K., Tanimoto, K., Murakami, K., Fukamizu, A. and Yagami, K., Speedy backcrossing through in vitro fertilization using prepubertal super-ovulation and neonatal death dependent on genetic background in angiotensinogen-deficient mice, Lab. Anim. Sci., (1997) in press.
21. Swanson, G.N., Hanesworth, J.M., Sardinia, M.F., Coleman, J.K., Wright, J.W., Hall, K.L., Miller-Wing, A.V., Stobb, J.W., Cook, V.l., Harding, E.C. and Harding, J.W., Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor, Regul. Pept., 40 (1992) 409-419.
22. Tanimoto, K., Sugiyama, F., Goto, Y., Ishida, J., Takimoto, E., Yagami, K., Fukamizu, A. and Murakami, K., Angiotensinogen-deficient mice with hypotension, J. Biol. Chem., 269 (1994) 31334-31337.
23. Tsutsumi, K. and Saavedra, J.M., Characterization and development of angiotensin II receptors (AT1 and AT2) in rat brain, Am. J. Physiol., 261 (1991) R209-R216.
24. Unger, T., Badoer, E., Ganten, D., Lang, R.E. and Retting, R., Brain angiotensin: pathways in pharmacology, Circulation, 77 (1988) (Suppl. 1) I40-I54.